| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |